Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation (2017) Weber D, Jenq RR, Peled JU, Taur Y, Hiergeist A, Koestler J, Dettmer K, et al. Journal article Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT (2017) Heidenreich S, Ziagkos D, De Wreede LC, Van Biezen A, Finke J, Platzbecker U, Niederwieser D, et al. Journal article Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial (2017) Middeke JM, Herbst R, Parmentier S, Bug G, Hänel M, Stuhler G, Schäfer-Eckart K, et al. Journal article Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD (2016) Ho AD, Schetelig J, Bochtler T, Schaich M, Schaefer-Eckart K, Haenel M, Rösler W, et al. Journal article Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia (2014) Yoshimi A, Strahm B, Baumann I, Furlan I, Schwarz-Furlan S, Teigler-Schlegel A, Walther JU, et al. Journal article Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies (2014) Kremer A, Van Der Meijden ED, Honders MW, Pont MJ, Goeman JJ, Falkenburg JHF, Griffioen M Journal article